Kim Sablich - 05 Jun 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
EVP, GM of U.S.
Signature
By: /s/Adam Guttmann, as attorney in fact For: Kimbely Sablich
Issuer symbol
JAZZ
Transactions as of
05 Jun 2023
Net transactions value
-$270,098
Form type
4
Filing time
07 Jun 2023, 19:15:12 UTC
Previous filing
10 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Disposed to Issuer $270,098 -2,082 -6.8% $129.73 28,478 05 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.